APO Research
Talk to an analyst

APO RESEARCH · REPORT

Carbetocin (Duratocin)

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Carbetocin (Duratocin) Industry Growth and Trends Forecast to 2032

20 December 2025103 pages

Choose your research edition.

Industry ResearchCarbetocin (Duratocin) Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Carbetocin (Duratocin) Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Carbetocin (Duratocin) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Carbetocin (Duratocin) Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Carbetocin (Duratocin) Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Carbetocin (Duratocin) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Carbetocin (Duratocin) is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Carbetocin (Duratocin) is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Carbetocin (Duratocin) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Carbetocin (Duratocin) include Ferring Inc., Hangzhou Dayangchem Co. Ltd., Acinopeptide Co., Ltd., Polypeptide Laboraries France, Leap Labchem Co., Ltd, Clearsynth Canada INC., Chemos GmbH & Co. KG, Chemieliva Pharmaceutical Co., Ltd. and BOC Sciences, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Carbetocin (Duratocin) market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Carbetocin (Duratocin) market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Carbetocin (Duratocin) market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Carbetocin (Duratocin).

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Carbetocin (Duratocin) market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Carbetocin (Duratocin) Market by Company

Ferring Inc.

Hangzhou Dayangchem Co. Ltd.

Acinopeptide Co., Ltd.

Polypeptide Laboraries France

Leap Labchem Co., Ltd

Clearsynth Canada INC.

Chemos GmbH & Co. KG

Chemieliva Pharmaceutical Co., Ltd.

BOC Sciences

Beacon Pharmaceuticals Limited

Bachem AG

Acinopeptide Co., Ltd.

Carbetocin (Duratocin) Segment by Type

Carbetocin Tablets

Carbetocin Injection

Carbetocin (Duratocin) Segment by Application

Oxytocic

Antihemorrhagic

Uterotonic

Carbetocin (Duratocin) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Carbetocin (Duratocin) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Carbetocin (Duratocin) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Carbetocin (Duratocin).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Carbetocin (Duratocin) manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Carbetocin (Duratocin) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Carbetocin Tablets Table 2. Major Company of Carbetocin Injection Table 3. Global Carbetocin (Duratocin) Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Carbetocin (Duratocin) Sales by Type (2021-2026) & (k units) Table 5. Global Carbetocin (Duratocin) Sales Market Share in Volume by Type (2021-2026) Table 6. Global Carbetocin (Duratocin) Sales by Type (2021-2026) & (US$ Million) Table 7. Global Carbetocin (Duratocin) Sales Market Share in Value by Type (2021-2026) Table 8. Global Carbetocin (Duratocin) Price by Type (2021-2026) & (US$/unit) Table 9. Global Carbetocin (Duratocin) Sales by Type (2027-2032) & (k units) Table 10. Global Carbetocin (Duratocin) Sales Market Share in Volume by Type (2027-2032) Table 11. Global Carbetocin (Duratocin) Sales by Type (2027-2032) & (US$ Million) Table 12. Global Carbetocin (Duratocin) Sales Market Share in Value by Type (2027-2032) Table 13. Global Carbetocin (Duratocin) Price by Type (2027-2032) & (US$/unit) Table 14. North America Carbetocin (Duratocin) Sales by Type (2021-2026) & (k units) Table 15. North America Carbetocin (Duratocin) Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Carbetocin (Duratocin) Sales by Type (2021-2026) & (k units) Table 17. Europe Carbetocin (Duratocin) Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Carbetocin (Duratocin) Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific Carbetocin (Duratocin) Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Carbetocin (Duratocin) Sales by Type (2021-2026) & (k units) Table 21. Latin America Carbetocin (Duratocin) Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Carbetocin (Duratocin) Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa Carbetocin (Duratocin) Sales by Type (2021-2026) & (US$ Million) Table 24. Carbetocin (Duratocin) Industry Trends Table 25. Carbetocin (Duratocin) Industry Drivers Table 26. Carbetocin (Duratocin) Industry Opportunities and Challenges Table 27. Carbetocin (Duratocin) Industry Restraints Table 28. Global Carbetocin (Duratocin) Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Carbetocin (Duratocin) Revenue Market Share by Company (2021-2026) Table 30. Global Carbetocin (Duratocin) Sales by Company (2021-2026) & (k units) Table 31. Global Carbetocin (Duratocin) Sales Share by Company (2021-2026) Table 32. Global Carbetocin (Duratocin) Market Price by Company (2021-2026) & (US$/unit) Table 33. Global Carbetocin (Duratocin) Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Carbetocin (Duratocin) Major Company Production Sites and Headquarters Table 35. Global Carbetocin (Duratocin) Company, Product Type & Application Table 36. Global Carbetocin (Duratocin) Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Carbetocin (Duratocin) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Carbetocin (Duratocin) Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Carbetocin (Duratocin) Sales by Region (2021-2026) & (k units) Table 41. Global Carbetocin (Duratocin) Sales Market Share in Volume by Region (2021-2026) Table 42. Global Carbetocin (Duratocin) Sales by Region (2021-2026) & (US$ Million) Table 43. Global Carbetocin (Duratocin) Sales Market Share in Value by Region (2021-2026) Table 44. Global Carbetocin (Duratocin) Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 45. Global Carbetocin (Duratocin) Sales by Region (2027-2032) & (k units) Table 46. Global Carbetocin (Duratocin) Sales Market Share in Volume by Region (2027-2032) Table 47. Global Carbetocin (Duratocin) Sales by Region (2027-2032) & (US$ Million) Table 48. Global Carbetocin (Duratocin) Sales Market Share in Value by Region (2027-2032) Table 49. Global Carbetocin (Duratocin) Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 50. Global Carbetocin (Duratocin) Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Carbetocin (Duratocin) Sales by Application (2021-2026) & (k units) Table 52. Global Carbetocin (Duratocin) Sales Market Share in Volume by Application (2021-2026) Table 53. Global Carbetocin (Duratocin) Sales by Application (2021-2026) & (US$ Million) Table 54. Global Carbetocin (Duratocin) Sales Market Share in Value by Application (2021-2026) Table 55. Global Carbetocin (Duratocin) Price by Application (2021-2026) & (US$/unit) Table 56. Global Carbetocin (Duratocin) Sales by Application (2027-2032) & (k units) Table 57. Global Carbetocin (Duratocin) Sales Market Share in Volume by Application (2027-2032) Table 58. Global Carbetocin (Duratocin) Sales by Application (2027-2032) & (US$ Million) Table 59. Global Carbetocin (Duratocin) Sales Market Share in Value by Application (2027-2032) Table 60. Global Carbetocin (Duratocin) Price by Application (2027-2032) & (US$/unit) Table 61. North America Carbetocin (Duratocin) Sales by Application (2021-2026) & (k units) Table 62. North America Carbetocin (Duratocin) Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Carbetocin (Duratocin) Sales by Application (2021-2026) & (k units) Table 64. Europe Carbetocin (Duratocin) Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Carbetocin (Duratocin) Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific Carbetocin (Duratocin) Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Carbetocin (Duratocin) Sales by Application (2021-2026) & (k units) Table 68. Latin America Carbetocin (Duratocin) Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Carbetocin (Duratocin) Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa Carbetocin (Duratocin) Sales by Application (2021-2026) & (US$ Million) Table 71. Ferring Inc. Company Information Table 72. Ferring Inc. Business Overview Table 73. Ferring Inc. Carbetocin (Duratocin) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Ferring Inc. Carbetocin (Duratocin) Product Portfolio Table 75. Ferring Inc. Recent Development Table 76. Hangzhou Dayangchem Co. Ltd. Company Information Table 77. Hangzhou Dayangchem Co. Ltd. Business Overview Table 78. Hangzhou Dayangchem Co. Ltd. Carbetocin (Duratocin) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Hangzhou Dayangchem Co. Ltd. Carbetocin (Duratocin) Product Portfolio Table 80. Hangzhou Dayangchem Co. Ltd. Recent Development Table 81. Acinopeptide Co., Ltd. Company Information Table 82. Acinopeptide Co., Ltd. Business Overview Table 83. Acinopeptide Co., Ltd. Carbetocin (Duratocin) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Acinopeptide Co., Ltd. Carbetocin (Duratocin) Product Portfolio Table 85. Acinopeptide Co., Ltd. Recent Development Table 86. Polypeptide Laboraries France Company Information Table 87. Polypeptide Laboraries France Business Overview Table 88. Polypeptide Laboraries France Carbetocin (Duratocin) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Polypeptide Laboraries France Carbetocin (Duratocin) Product Portfolio Table 90. Polypeptide Laboraries France Recent Development Table 91. Leap Labchem Co., Ltd Company Information Table 92. Leap Labchem Co., Ltd Business Overview Table 93. Leap Labchem Co., Ltd Carbetocin (Duratocin) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Leap Labchem Co., Ltd Carbetocin (Duratocin) Product Portfolio Table 95. Leap Labchem Co., Ltd Recent Development Table 96. Clearsynth Canada INC. Company Information Table 97. Clearsynth Canada INC. Business Overview Table 98. Clearsynth Canada INC. Carbetocin (Duratocin) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. Clearsynth Canada INC. Carbetocin (Duratocin) Product Portfolio Table 100. Clearsynth Canada INC. Recent Development Table 101. Chemos GmbH & Co. KG Company Information Table 102. Chemos GmbH & Co. KG Business Overview Table 103. Chemos GmbH & Co. KG Carbetocin (Duratocin) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. Chemos GmbH & Co. KG Carbetocin (Duratocin) Product Portfolio Table 105. Chemos GmbH & Co. KG Recent Development Table 106. Chemieliva Pharmaceutical Co., Ltd. Company Information Table 107. Chemieliva Pharmaceutical Co., Ltd. Business Overview Table 108. Chemieliva Pharmaceutical Co., Ltd. Carbetocin (Duratocin) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 109. Chemieliva Pharmaceutical Co., Ltd. Carbetocin (Duratocin) Product Portfolio Table 110. Chemieliva Pharmaceutical Co., Ltd. Recent Development Table 111. BOC Sciences Company Information Table 112. BOC Sciences Business Overview Table 113. BOC Sciences Carbetocin (Duratocin) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 114. BOC Sciences Carbetocin (Duratocin) Product Portfolio Table 115. BOC Sciences Recent Development Table 116. Beacon Pharmaceuticals Limited Company Information Table 117. Beacon Pharmaceuticals Limited Business Overview Table 118. Beacon Pharmaceuticals Limited Carbetocin (Duratocin) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 119. Beacon Pharmaceuticals Limited Carbetocin (Duratocin) Product Portfolio Table 120. Beacon Pharmaceuticals Limited Recent Development Table 121. Bachem AG Company Information Table 122. Bachem AG Business Overview Table 123. Bachem AG Carbetocin (Duratocin) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 124. Bachem AG Carbetocin (Duratocin) Product Portfolio Table 125. Bachem AG Recent Development Table 126. Acinopeptide Co., Ltd. Company Information Table 127. Acinopeptide Co., Ltd. Business Overview Table 128. Acinopeptide Co., Ltd. Carbetocin (Duratocin) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 129. Acinopeptide Co., Ltd. Carbetocin (Duratocin) Product Portfolio Table 130. Acinopeptide Co., Ltd. Recent Development Table 131. North America Carbetocin (Duratocin) Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 132. North America Carbetocin (Duratocin) Sales by Country (2021-2026) & (k units) Table 133. North America Carbetocin (Duratocin) Sales Market Share by Country (2021-2026) Table 134. North America Carbetocin (Duratocin) Sales Forecast by Country (2027-2032) & (k units) Table 135. North America Carbetocin (Duratocin) Sales Market Share Forecast by Country (2027-2032) Table 136. North America Carbetocin (Duratocin) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. North America Carbetocin (Duratocin) Market Size by Country (2021-2026) & (US$ Million) Table 138. North America Carbetocin (Duratocin) Market Share by Country (2021-2026) Table 139. North America Carbetocin (Duratocin) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. North America Carbetocin (Duratocin) Market Share Forecast by Country (2027-2032) Table 141. Europe Carbetocin (Duratocin) Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 142. Europe Carbetocin (Duratocin) Sales by Country (2021-2026) & (k units) Table 143. Europe Carbetocin (Duratocin) Sales Market Share by Country (2021-2026) Table 144. Europe Carbetocin (Duratocin) Sales Forecast by Country (2027-2032) & (k units) Table 145. Europe Carbetocin (Duratocin) Sales Market Share Forecast by Country (2027-2032) Table 146. Europe Carbetocin (Duratocin) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Europe Carbetocin (Duratocin) Market Size by Country (2021-2026) & (US$ Million) Table 148. Europe Carbetocin (Duratocin) Market Share by Country (2021-2026) Table 149. Europe Carbetocin (Duratocin) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Europe Carbetocin (Duratocin) Market Share Forecast by Country (2027-2032) Table 151. Asia-Pacific Carbetocin (Duratocin) Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 152. Asia-Pacific Carbetocin (Duratocin) Sales by Country (2021-2026) & (k units) Table 153. Asia-Pacific Carbetocin (Duratocin) Sales Market Share by Country (2021-2026) Table 154. Asia-Pacific Carbetocin (Duratocin) Sales Forecast by Country (2027-2032) & (k units) Table 155. Asia-Pacific Carbetocin (Duratocin) Sales Market Share Forecast by Country (2027-2032) Table 156. Asia-Pacific Carbetocin (Duratocin) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Asia-Pacific Carbetocin (Duratocin) Market Size by Country (2021-2026) & (US$ Million) Table 158. Asia-Pacific Carbetocin (Duratocin) Market Share by Country (2021-2026) Table 159. Asia-Pacific Carbetocin (Duratocin) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Asia-Pacific Carbetocin (Duratocin) Market Share Forecast by Country (2027-2032) Table 161. Latin America Carbetocin (Duratocin) Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 162. Latin America Carbetocin (Duratocin) Sales by Country (2021-2026) & (k units) Table 163. Latin America Carbetocin (Duratocin) Sales Market Share by Country (2021-2026) Table 164. Latin America Carbetocin (Duratocin) Sales Forecast by Country (2027-2032) & (k units) Table 165. Latin America Carbetocin (Duratocin) Sales Market Share Forecast by Country (2027-2032) Table 166. Latin America Carbetocin (Duratocin) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Latin America Carbetocin (Duratocin) Market Size by Country (2021-2026) & (US$ Million) Table 168. Latin America Carbetocin (Duratocin) Market Share by Country (2021-2026) Table 169. Latin America Carbetocin (Duratocin) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Latin America Carbetocin (Duratocin) Market Share Forecast by Country (2027-2032) Table 171. Middle East and Africa Carbetocin (Duratocin) Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 172. Middle East and Africa Carbetocin (Duratocin) Sales by Country (2021-2026) & (k units) Table 173. Middle East and Africa Carbetocin (Duratocin) Sales Market Share by Country (2021-2026) Table 174. Middle East and Africa Carbetocin (Duratocin) Sales Forecast by Country (2027-2032) & (k units) Table 175. Middle East and Africa Carbetocin (Duratocin) Sales Market Share Forecast by Country (2027-2032) Table 176. Middle East and Africa Carbetocin (Duratocin) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 177. Middle East and Africa Carbetocin (Duratocin) Market Size by Country (2021-2026) & (US$ Million) Table 178. Middle East and Africa Carbetocin (Duratocin) Market Share by Country (2021-2026) Table 179. Middle East and Africa Carbetocin (Duratocin) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 180. Middle East and Africa Carbetocin (Duratocin) Market Share Forecast by Country (2027-2032) Table 181. Key Raw Materials Table 182. Raw Materials Key Suppliers Table 183. Carbetocin (Duratocin) Distributors List Table 184. Carbetocin (Duratocin) Customers List Table 185. Research Programs/Design for This Report Table 186. Authors List of This Report Table 187. Secondary Sources Table 188. Primary Sources List of Figures Figure 1. Carbetocin (Duratocin) Image Figure 2. Global Carbetocin (Duratocin) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Carbetocin (Duratocin) Market Size (2021-2032) & (US$ Million) Figure 4. Global Carbetocin (Duratocin) Sales (2021-2032) & (k units) Figure 5. Carbetocin Tablets Image Figure 6. Global Carbetocin Tablets Sales YoY Growth (2021-2032) & (k units) Figure 7. Carbetocin Injection Image Figure 8. Global Carbetocin Injection Sales YoY Growth (2021-2032) & (k units) Figure 9. Global Carbetocin (Duratocin) Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Carbetocin (Duratocin) Market Share by Type 2025 VS 2032 Figure 11. North America Carbetocin (Duratocin) Sales Market Share in Volume by Type in 2025 Figure 12. North America Carbetocin (Duratocin) Sales Market Share in Value by Type in 2025 Figure 13. Europe Carbetocin (Duratocin) Sales Market Share in Volume by Type in 2025 Figure 14. Europe Carbetocin (Duratocin) Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Carbetocin (Duratocin) Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Carbetocin (Duratocin) Sales Market Share in Value by Type in 2025 Figure 17. Latin America Carbetocin (Duratocin) Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Carbetocin (Duratocin) Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Carbetocin (Duratocin) Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Carbetocin (Duratocin) Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Carbetocin (Duratocin) Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Oxytocic Image Figure 24. Global Oxytocic Sales YoY Growth (2021-2032) & (k units) Figure 25. Antihemorrhagic Image Figure 26. Global Antihemorrhagic Sales YoY Growth (2021-2032) & (k units) Figure 27. Uterotonic Image Figure 28. Global Uterotonic Sales YoY Growth (2021-2032) & (k units) Figure 29. Global Carbetocin (Duratocin) Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Carbetocin (Duratocin) Market Share by Application 2025 VS 2032 Figure 31. North America Carbetocin (Duratocin) Sales Market Share in Volume by Application in 2025 Figure 32. North America Carbetocin (Duratocin) Sales Market Share in Value by Application in 2025 Figure 33. Europe Carbetocin (Duratocin) Sales Market Share in Volume by Application in 2025 Figure 34. Europe Carbetocin (Duratocin) Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Carbetocin (Duratocin) Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Carbetocin (Duratocin) Sales Market Share in Value by Application in 2025 Figure 37. Latin America Carbetocin (Duratocin) Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Carbetocin (Duratocin) Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Carbetocin (Duratocin) Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Carbetocin (Duratocin) Sales Market Share in Value by Application in 2025 Figure 41. North America Carbetocin (Duratocin) Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 42. North America Carbetocin (Duratocin) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Carbetocin (Duratocin) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Carbetocin (Duratocin) Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Carbetocin (Duratocin) Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 46. Europe Carbetocin (Duratocin) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Carbetocin (Duratocin) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Carbetocin (Duratocin) Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Carbetocin (Duratocin) Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. Asia-Pacific Carbetocin (Duratocin) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Carbetocin (Duratocin) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Carbetocin (Duratocin) Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Carbetocin (Duratocin) Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Latin America Carbetocin (Duratocin) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Carbetocin (Duratocin) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Carbetocin (Duratocin) Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Carbetocin (Duratocin) Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Middle East and Africa Carbetocin (Duratocin) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Carbetocin (Duratocin) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Carbetocin (Duratocin) Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Carbetocin (Duratocin) Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Carbetocin (Duratocin) Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Carbetocin Tablets
  • Carbetocin Injection
Applications
  • Oxytocic
  • Antihemorrhagic
  • Uterotonic
Companies covered
  • Ferring Inc.
  • Hangzhou Dayangchem Co. Ltd.
  • Acinopeptide Co., Ltd.
  • Polypeptide Laboraries France
  • Leap Labchem Co., Ltd
  • Clearsynth Canada INC.
  • Chemos GmbH & Co. KG
  • Chemieliva Pharmaceutical Co., Ltd.
  • BOC Sciences
  • Beacon Pharmaceuticals Limited
  • Bachem AG
  • Acinopeptide Co., Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Carbetocin (Duratocin) Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Carbetocin (Duratocin) Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Carbetocin (Duratocin) Market by Type
  6. 1.3.1 Carbetocin Tablets
  7. 1.3.2 Carbetocin Injection
  8. 1.4 Global Carbetocin (Duratocin) Market Size by Type
  9. 1.4.1 Global Carbetocin (Duratocin) Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Carbetocin (Duratocin) Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Carbetocin (Duratocin) Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Carbetocin (Duratocin) Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Carbetocin (Duratocin) Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Carbetocin (Duratocin) Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Carbetocin (Duratocin) Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Carbetocin (Duratocin) Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Carbetocin (Duratocin) Industry Trends
  2. 2.2 Carbetocin (Duratocin) Industry Drivers
  3. 2.3 Carbetocin (Duratocin) Industry Opportunities and Challenges
  4. 2.4 Carbetocin (Duratocin) Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Carbetocin (Duratocin) Revenue (2021-2026)
  2. 3.2 Global Top Players by Carbetocin (Duratocin) Sales (2021-2026)
  3. 3.3 Global Top Players by Carbetocin (Duratocin) Price (2021-2026)
  4. 3.4 Global Carbetocin (Duratocin) Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Carbetocin (Duratocin) Major Company Production Sites & Headquarters
  6. 3.6 Global Carbetocin (Duratocin) Company, Product Type & Application
  7. 3.7 Global Carbetocin (Duratocin) Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Carbetocin (Duratocin) Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Carbetocin (Duratocin) Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Carbetocin (Duratocin) Tier 1, Tier 2, and Tier 3
4 Carbetocin (Duratocin) Regional Status and Outlook
  1. 4.1 Global Carbetocin (Duratocin) Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Carbetocin (Duratocin) Historic Market Size by Region
  3. 4.2.1 Global Carbetocin (Duratocin) Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Carbetocin (Duratocin) Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Carbetocin (Duratocin) Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Carbetocin (Duratocin) Forecasted Market Size by Region
  7. 4.3.1 Global Carbetocin (Duratocin) Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Carbetocin (Duratocin) Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Carbetocin (Duratocin) Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Carbetocin (Duratocin) by Application
  1. 5.1 Carbetocin (Duratocin) Market by Application
  2. 5.1.1 Oxytocic
  3. 5.1.2 Antihemorrhagic
  4. 5.1.3 Uterotonic
  5. 5.2 Global Carbetocin (Duratocin) Market Size by Application
  6. 5.2.1 Global Carbetocin (Duratocin) Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Carbetocin (Duratocin) Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Carbetocin (Duratocin) Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Carbetocin (Duratocin) Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Carbetocin (Duratocin) Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Carbetocin (Duratocin) Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Carbetocin (Duratocin) Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Carbetocin (Duratocin) Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Ferring Inc.
  2. 6.1.1 Ferring Inc. Company Information
  3. 6.1.2 Ferring Inc. Business Overview
  4. 6.1.3 Ferring Inc. Carbetocin (Duratocin) Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Ferring Inc. Carbetocin (Duratocin) Product Portfolio
  6. 6.1.5 Ferring Inc. Recent Developments
  7. 6.2 Hangzhou Dayangchem Co. Ltd.
  8. 6.2.1 Hangzhou Dayangchem Co. Ltd. Company Information
  9. 6.2.2 Hangzhou Dayangchem Co. Ltd. Business Overview
  10. 6.2.3 Hangzhou Dayangchem Co. Ltd. Carbetocin (Duratocin) Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Hangzhou Dayangchem Co. Ltd. Carbetocin (Duratocin) Product Portfolio
  12. 6.2.5 Hangzhou Dayangchem Co. Ltd. Recent Developments
  13. 6.3 Acinopeptide Co., Ltd.
  14. 6.3.1 Acinopeptide Co., Ltd. Company Information
  15. 6.3.2 Acinopeptide Co., Ltd. Business Overview
  16. 6.3.3 Acinopeptide Co., Ltd. Carbetocin (Duratocin) Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Acinopeptide Co., Ltd. Carbetocin (Duratocin) Product Portfolio
  18. 6.3.5 Acinopeptide Co., Ltd. Recent Developments
  19. 6.4 Polypeptide Laboraries France
  20. 6.4.1 Polypeptide Laboraries France Company Information
  21. 6.4.2 Polypeptide Laboraries France Business Overview
  22. 6.4.3 Polypeptide Laboraries France Carbetocin (Duratocin) Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Polypeptide Laboraries France Carbetocin (Duratocin) Product Portfolio
  24. 6.4.5 Polypeptide Laboraries France Recent Developments
  25. 6.5 Leap Labchem Co., Ltd
  26. 6.5.1 Leap Labchem Co., Ltd Company Information
  27. 6.5.2 Leap Labchem Co., Ltd Business Overview
  28. 6.5.3 Leap Labchem Co., Ltd Carbetocin (Duratocin) Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Leap Labchem Co., Ltd Carbetocin (Duratocin) Product Portfolio
  30. 6.5.5 Leap Labchem Co., Ltd Recent Developments
  31. 6.6 Clearsynth Canada INC.
  32. 6.6.1 Clearsynth Canada INC. Company Information
  33. 6.6.2 Clearsynth Canada INC. Business Overview
  34. 6.6.3 Clearsynth Canada INC. Carbetocin (Duratocin) Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Clearsynth Canada INC. Carbetocin (Duratocin) Product Portfolio
  36. 6.6.5 Clearsynth Canada INC. Recent Developments
  37. 6.7 Chemos GmbH & Co. KG
  38. 6.7.1 Chemos GmbH & Co. KG Company Information
  39. 6.7.2 Chemos GmbH & Co. KG Business Overview
  40. 6.7.3 Chemos GmbH & Co. KG Carbetocin (Duratocin) Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Chemos GmbH & Co. KG Carbetocin (Duratocin) Product Portfolio
  42. 6.7.5 Chemos GmbH & Co. KG Recent Developments
  43. 6.8 Chemieliva Pharmaceutical Co., Ltd.
  44. 6.8.1 Chemieliva Pharmaceutical Co., Ltd. Company Information
  45. 6.8.2 Chemieliva Pharmaceutical Co., Ltd. Business Overview
  46. 6.8.3 Chemieliva Pharmaceutical Co., Ltd. Carbetocin (Duratocin) Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Chemieliva Pharmaceutical Co., Ltd. Carbetocin (Duratocin) Product Portfolio
  48. 6.8.5 Chemieliva Pharmaceutical Co., Ltd. Recent Developments
  49. 6.9 BOC Sciences
  50. 6.9.1 BOC Sciences Company Information
  51. 6.9.2 BOC Sciences Business Overview
  52. 6.9.3 BOC Sciences Carbetocin (Duratocin) Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 BOC Sciences Carbetocin (Duratocin) Product Portfolio
  54. 6.9.5 BOC Sciences Recent Developments
  55. 6.10 Beacon Pharmaceuticals Limited
  56. 6.10.1 Beacon Pharmaceuticals Limited Company Information
  57. 6.10.2 Beacon Pharmaceuticals Limited Business Overview
  58. 6.10.3 Beacon Pharmaceuticals Limited Carbetocin (Duratocin) Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Beacon Pharmaceuticals Limited Carbetocin (Duratocin) Product Portfolio
  60. 6.10.5 Beacon Pharmaceuticals Limited Recent Developments
  61. 6.11 Bachem AG
  62. 6.11.1 Bachem AG Company Information
  63. 6.11.2 Bachem AG Business Overview
  64. 6.11.3 Bachem AG Carbetocin (Duratocin) Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Bachem AG Carbetocin (Duratocin) Product Portfolio
  66. 6.11.5 Bachem AG Recent Developments
  67. 6.12 Acinopeptide Co., Ltd.
  68. 6.12.1 Acinopeptide Co., Ltd. Company Information
  69. 6.12.2 Acinopeptide Co., Ltd. Business Overview
  70. 6.12.3 Acinopeptide Co., Ltd. Carbetocin (Duratocin) Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Acinopeptide Co., Ltd. Carbetocin (Duratocin) Product Portfolio
  72. 6.12.5 Acinopeptide Co., Ltd. Recent Developments
7 North America by Country
  1. 7.1 North America Carbetocin (Duratocin) Sales by Country
  2. 7.1.1 North America Carbetocin (Duratocin) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Carbetocin (Duratocin) Sales by Country (2021-2026)
  4. 7.1.3 North America Carbetocin (Duratocin) Sales Forecast by Country (2027-2032)
  5. 7.2 North America Carbetocin (Duratocin) Market Size by Country
  6. 7.2.1 North America Carbetocin (Duratocin) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Carbetocin (Duratocin) Market Size by Country (2021-2026)
  8. 7.2.3 North America Carbetocin (Duratocin) Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Carbetocin (Duratocin) Sales by Country
  2. 8.1.1 Europe Carbetocin (Duratocin) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Carbetocin (Duratocin) Sales by Country (2021-2026)
  4. 8.1.3 Europe Carbetocin (Duratocin) Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Carbetocin (Duratocin) Market Size by Country
  6. 8.2.1 Europe Carbetocin (Duratocin) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Carbetocin (Duratocin) Market Size by Country (2021-2026)
  8. 8.2.3 Europe Carbetocin (Duratocin) Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Carbetocin (Duratocin) Sales by Country
  2. 9.1.1 Asia-Pacific Carbetocin (Duratocin) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Carbetocin (Duratocin) Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Carbetocin (Duratocin) Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Carbetocin (Duratocin) Market Size by Country
  6. 9.2.1 Asia-Pacific Carbetocin (Duratocin) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Carbetocin (Duratocin) Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Carbetocin (Duratocin) Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Carbetocin (Duratocin) Sales by Country
  2. 10.1.1 South America Carbetocin (Duratocin) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Carbetocin (Duratocin) Sales by Country (2021-2026)
  4. 10.1.3 South America Carbetocin (Duratocin) Sales Forecast by Country (2027-2032)
  5. 10.2 South America Carbetocin (Duratocin) Market Size by Country
  6. 10.2.1 South America Carbetocin (Duratocin) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Carbetocin (Duratocin) Market Size by Country (2021-2026)
  8. 10.2.3 South America Carbetocin (Duratocin) Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Carbetocin (Duratocin) Sales by Country
  2. 11.1.1 Middle East and Africa Carbetocin (Duratocin) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Carbetocin (Duratocin) Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Carbetocin (Duratocin) Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Carbetocin (Duratocin) Market Size by Country
  6. 11.2.1 Middle East and Africa Carbetocin (Duratocin) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Carbetocin (Duratocin) Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Carbetocin (Duratocin) Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Carbetocin (Duratocin) Value Chain Analysis
  2. 12.1.1 Carbetocin (Duratocin) Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Carbetocin (Duratocin) Production Mode & Process
  7. 12.2 Carbetocin (Duratocin) Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Carbetocin (Duratocin) Distributors
  10. 12.2.3 Carbetocin (Duratocin) Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst